Afimkibart
Based on 1 publication(s) in Google Scholar
Afimkibart (PF-06480605; RVT-3101) is a fully human monoclonal antibody that selectively inhibits trimeric tumor necrosis factor-like ligand 1A (TL1A). Afimkibart neutralizes active trimeric TL1A, blocks TL1A-induced signaling pathways. Afimkibart inhibits NF-κB activation and IFN-γ production. Afimkibart can be used for the research of inflammatory bowel disease.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza: 99.59%
- No. CAS: 2911580-96-4
- Peso molecular:146.54 kDa
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Afimkibart
MoreVer todos los productos específicos de isoformas TNF Receptor
More
Actividad biológica
Human IgG1 kappa
Human
|
TL1A |
Afimkibart selectively binds to functionally active trimeric recombinant human TL1A and does not bind to monomeric recombinant human TL1A[1].
Afimkibart potently inhibits trimeric recombinant human TL1A-induced NF-κB activation in human peripheral T lymphocytes and trimeric recombinant human TL1A/IL12/IL18-induced IFN-γ production in human PBMCs[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
IgG1-kappa
ELISA, FACS, Functional assay
-
Immobilized TL1A/TNFSF15 Trimer Protein, Human can bind Afimkibart. The EC50 for this effect is 8.563 ng/mL. -
Flow cytometric analysis of 1.5X106 HT-29 cells with Afimkibart (HY-P990876, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa, Isotype Control (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
Chemical Information
-
No. CAS 2911580-96-4
-
Appearance Liquid
-
Peso molecular 146.54 kDa
-
Color Colorless to light yellow
-
SMILES
[Afimkibart]
-
Synonyms
PF-06480605; RVT-3101
-
Envío
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Inflamm Bowel Dis
Preclinical development of SL-325, a novel high-affinity DR3-blocking antibody for durable inhibition of the DR3/TL1A axis in inflammatory bowel disease. [Abstract]2026 Jun 27:izag101. PMID: 42364076
Pureza y Documentación
-
Ficha de datos (256 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- Afimkibart
- 2911580-96-4
- PF-06480605
- RVT-3101
- PF06480605
- PF 06480605
- RVT3101
- RVT 3101
- RVT-3101
- TNF Receptor
- NF-κB
- IFNAR
- peripheral T lymphocytes
- IFN-γ
- endogenous active TL1A
- TL1A
- Tumor necrosis factor-like ligand 1A
- inflammatory bowel disease
- human peripheral blood mononuclear cells
- interferon-gamma
- human PBMCs
- Inhibitor
- inhibitor
- inhibit